Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Impact of early systemic lupus erythematosus on work disability-results from the Finnish nationwide register 2000-2007.

Elfving P, Puolakka K, Rantalaiho V, Kautiainen H, Virta LJ, Kaipiainen-Seppänen O.

Clin Rheumatol. 2018 May;37(5):1413-1416. doi: 10.1007/s10067-018-4066-6. Epub 2018 Mar 14.

PMID:
29541950
2.

Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial.

Väänänen T, Vuolteenaho K, Kautiainen H, Nieminen R, Möttönen T, Hannonen P, Korpela M, Kauppi MJ, Laiho K, Kaipiainen-Seppänen O, Luosujärvi R, Uusitalo T, Uutela T, Leirisalo-Repo M, Moilanen E; NEO-RACo Study Group.

PLoS One. 2017 Aug 25;12(8):e0183294. doi: 10.1371/journal.pone.0183294. eCollection 2017.

3.

Incidence of inflammatory joint diseases in Finland: results from a population-based epidemiological study.

Kononoff A, Arstila L, Pussinen P, Kautiainen H, Elfving P, Savolainen E, Niinisalo H, Rutanen J, Marjoniemi O, Kaipiainen-Seppänen O.

Rheumatol Int. 2017 Oct;37(10):1693-1700. doi: 10.1007/s00296-017-3779-1. Epub 2017 Aug 8.

PMID:
28791449
4.

Profile of initial drug therapy in paediatric systemic lupus erythematosus in Finland, 2000-2007.

Elfving P, Puolakka K, Kautiainen H, Virta LJ, Pohjolainen T, Kaipiainen-Seppänen O.

Clin Exp Rheumatol. 2017 Mar-Apr;35(2):352. Epub 2017 Jan 15. No abstract available.

PMID:
28094755
5.

Intra-articular glucocorticoid injections should not be neglected in the remission targeted treatment of early rheumatoid arthritis: a post hoc analysis from the NEO-RACo trial.

Kuusalo LA, Puolakka KT, Kautiainen H, Alasaarela EM, Hannonen PJ, Julkunen HA, Kaipiainen-Seppänen OA, Korpela MM, Möttönen TT, Paimela LH, Peltomaa RL, Yli-Kerttula TK, Leirisalo-Repo M, Rantalaiho VM; NEO-RACo Study Group.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1038-1044. Epub 2016 Aug 2.

PMID:
27494516
6.

Estimating the incidence of connective tissue diseases and vasculitides in a defined population in Northern Savo area in 2010.

Elfving P, Marjoniemi O, Niinisalo H, Kononoff A, Arstila L, Savolainen E, Rutanen J, Kaipiainen-Seppänen O.

Rheumatol Int. 2016 Jul;36(7):917-24. doi: 10.1007/s00296-016-3474-7. Epub 2016 Apr 6.

PMID:
27053177
7.

Drugs used in incident systemic lupus erythematosus - results from the Finnish nationwide register 2000-2007.

Elfving P, Puolakka K, Kautiainen H, Virta LJ, Pohjolainen T, Kaipiainen-Seppänen O.

Lupus. 2016 May;25(6):666-70. doi: 10.1177/0961203316628998. Epub 2016 Jan 27.

PMID:
26821964
8.

Impact of physicians' adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial.

Kuusalo L, Puolakka K, Kautiainen H, Blåfield H, Eklund KK, Ilva K, Kaipiainen-Seppänen O, Karjalainen A, Korpela M, Valleala H, Leirisalo-Repo M, Rantalaiho V; Neo-RACo Study Group.

Scand J Rheumatol. 2015;44(6):449-55. doi: 10.3109/03009742.2015.1043142. Epub 2015 Aug 31.

PMID:
26324784
9.

Automated immunoassays for the autoantibodies to carbamylated or citrullinated telopeptides of type I and II collagens.

Häyrynen J, Kärkkäinen M, Kononoff A, Arstila L, Elfving P, Niinisalo H, Savolainen E, Kautiainen H, Risteli J, Kaipiainen-Seppänen O, Koivula MK.

Clin Chem Lab Med. 2015 Aug;53(9):1375-80. doi: 10.1515/cclm-2014-0683.

PMID:
25389994
10.

Incidence of systemic lupus erythematosus in Finland, 2000-2007, a nationwide study.

Elfving P, Puolakka K, Kautiainen H, Virta LJ, Pohjolainen T, Kaipiainen-Seppänen O.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):953-5. Epub 2014 Oct 20.

PMID:
25328038
11.

Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months: the 5-year followup results of the randomized clinical NEO-RACo trial.

Rantalaiho V, Kautiainen H, Järvenpää S, Korpela M, Malmi T, Hannonen P, Kaipiainen-Seppänen O, Yli-Kerttula T, Möttönen T, Mustila A, Karjalainen A, Paimela L, Uutela T, Leirisalo-Repo M; NEO-RACo Study Group.

J Rheumatol. 2014 Dec;41(12):2379-85. doi: 10.3899/jrheum.140267. Epub 2014 Oct 1.

PMID:
25274892
12.

Mortality and causes of death among incident cases of systemic lupus erythematosus in Finland 2000-2008.

Elfving P, Puolakka K, Kautiainen H, Virta LJ, Pohjolainen T, Kaipiainen-Seppänen O.

Lupus. 2014 Nov;23(13):1430-4. doi: 10.1177/0961203314543919. Epub 2014 Jul 23.

PMID:
25057036
13.

Five cases of interstitial lung disease after leflunomide was combined with methotrexate therapy.

Rutanen J, Kononoff A, Arstila L, Elfving P, Koskela H, Kaipiainen-Seppänen O.

Scand J Rheumatol. 2014;43(3):254-6. doi: 10.3109/03009742.2013.868511. Epub 2014 Mar 21. No abstract available.

PMID:
24650220
14.

Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial.

Rantalaiho V, Kautiainen H, Korpela M, Hannonen P, Kaipiainen-Seppänen O, Möttönen T, Kauppi M, Karjalainen A, Laiho K, Laasonen L, Hakola M, Peltomaa R, Leirisalo-Repo M; NEO-RACo Study Group.

Ann Rheum Dis. 2014 Nov;73(11):1954-61. doi: 10.1136/annrheumdis-2013-203497. Epub 2013 Aug 1.

PMID:
23908187
15.

Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study).

Leirisalo-Repo M, Kautiainen H, Laasonen L, Korpela M, Kauppi MJ, Kaipiainen-Seppänen O, Luosujärvi R, Luukkainen R, Karjalainen A, Blåfield H, Uutela T, Ilva K, Julkunen HA, Paimela L, Puolakka K, Moilanen E, Hannonen PJ, Möttönen T; NEO-RACo Study Group.

Ann Rheum Dis. 2013 Jun;72(6):851-7. doi: 10.1136/annrheumdis-2012-201365. Epub 2012 Jun 30.

PMID:
22753402
16.

[Chest, skin and joint symptoms of a middle-aged man].

Kaipiainen-Seppänen O, Lamminen A.

Duodecim. 2012;128(3):298-306. Finnish.

PMID:
22428384
17.

Renal safety of initial combination versus single DMARD therapy in patients with early rheumatoid arthritis: an 11-year experience from the FIN-RACo Trial.

Karstila KL, Rantalaiho VM, Mustonen JT, Möttönen TT, Hannonen PJ, Leirisalo-Repo M, Kaipiainen-Seppänen OA, Karjalainen AH, Korpela MM; FIN-RACo Trial Group.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1):73-8.

PMID:
20346242
18.

[Adverse muscle effects of a podofyllotoxin-containing cytotoxic drug product with simvastatin].

Kaipiainen-Seppänen O, Savolainen E, Elfving P, Kononoff A.

Duodecim. 2009;125(7):788-91. Finnish.

PMID:
19432085
19.

Prevalence of antibodies against Chlamydia trachomatis and incidence of C. trachomatis-induced reactive arthritis in an early arthritis series in Finland in 2000.

Savolainen E, Kettunen A, Närvänen A, Kautiainen H, Kärkkäinen U, Luosujärvi R, Kaipiainen-Seppänen O.

Scand J Rheumatol. 2009;38(5):353-6. doi: 10.1080/03009740902769559.

PMID:
19296404
20.

Serum soluble CD30 in early arthritis: a sign of inflammation but not a predictor of outcome.

Savolainen E, Matinlauri I, Kautiainen H, Luosujärvi R, Kaipiainen-Seppänen O.

Clin Exp Rheumatol. 2008 Sep-Oct;26(5):922-5.

PMID:
19032830
21.

Sensitivity and specificity of autoantibodies binding to citrullinated carboxyterminal telopeptides of types I and II collagens in an early arthritis series.

Koivula MK, Savolainen E, Kaipiainen-Seppänen O, Kautiainen H, Luosujärvi R, Hakala M, Risteli J.

Rheumatology (Oxford). 2008 May;47(5):656-9. doi: 10.1093/rheumatology/ken092. Epub 2008 Mar 20.

PMID:
18356174
22.

Two pathogenic CIAS1 mutations and plasma cytokine profile in a Finnish patient with familial cold autoinflammatory syndrome responsive to anakinra.

Kaipiainen-Seppänen O, Punnonen K, van Gijn ME, Mononen T.

Scand J Rheumatol. 2008 Jan-Feb;37(1):75-6. doi: 10.1080/03009740701691491. No abstract available.

PMID:
18189199
23.
24.

Change of diagnoses and outcome of patients with early inflammatory joint diseases during a mean 13-month follow-up.

Savolainen E, Kautiainen H, Koivula MK, Luosujärvi R, Risteli J, Kaipiainen-Seppänen O.

Scand J Rheumatol. 2007 May-Jun;36(3):194-7.

PMID:
17657673
25.

Amyopaattiseen dermatomyosiittiin liittyvä interstitiaalinen keuhkosairaus.

Koskela H, Kaipiainen-Seppänen O.

Duodecim. 2006;122(19):2349-51. Finnish. No abstract available.

PMID:
17115543
26.

Declining trend in the incidence of rheumatoid factor-positive rheumatoid arthritis in Finland 1980-2000.

Kaipiainen-Seppanen O, Kautiainen H.

J Rheumatol. 2006 Nov;33(11):2132-8. Epub 2006 Oct 1.

PMID:
17014003
27.

Sitrulliinivasta-aineet niveltulehdustautien diagnostiikassa.

Kaipiainen-Seppänen O.

Duodecim. 2006;122(6):694; author reply 695. Finnish. No abstract available.

PMID:
16683367
28.

Classic disease modifying anti-rheumatic drugs (DMARDs) in combination with infliximab. The Finnish experience.

Nordström DC, Konttinen L, Korpela M, Tiippana-Kinnunen T, Eklund K, Forsberg S, Ilva K, Kaipiainen-Seppänen O, Malmi T, Ylä-Kerttula T, Honkanen V.

Rheumatol Int. 2006 Jun;26(8):741-8. Epub 2005 Oct 5.

PMID:
16205925
29.

[Epidemiology of rheumatoid arthritis in Finland].

Kaipiainen-Seppänen O.

Duodecim. 2004;120(3):283-7. Review. Finnish. No abstract available.

PMID:
15061005
30.

Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey.

Savolainen E, Kaipiainen-Seppänen O, Kröger L, Luosujärvi R.

J Rheumatol. 2003 Nov;30(11):2460-8.

PMID:
14677193
31.

Joint symptoms and diseases associated with moisture damage in a health center.

Luosujärvi RA, Husman TM, Seuri M, Pietikäinen MA, Pollari P, Pelkonen J, Hujakka HT, Kaipiainen-Seppänen OA, Aho K.

Clin Rheumatol. 2003 Dec;22(6):381-5. Epub 2003 Oct 14.

PMID:
14677010
32.

Regional differences in Finland in the prevalence of rheumatoid factor in the presence and absence of arthritis.

Korpilähde T, Heliövaara M, Kaipiainen-Seppänen O, Knekt P, Aho K.

Ann Rheum Dis. 2003 Apr;62(4):353-5.

33.

Recurrent myopericarditis in association with Crohn's disease.

Hyttinen L, Kaipiainen-Seppänen O, Halinen M.

J Intern Med. 2003 Mar;253(3):386-8.

34.

Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumour necrosis factor alpha inhibitors.

Kaipiainen-Seppänen O, Leino M.

Ann Rheum Dis. 2003 Jan;62(1):88-9. Review. No abstract available.

35.

[Ocular perforations in patient with rheumatoid arthritis and dry eye syndrome].

Kaipiainen-Seppänen O, Tuppurainen K.

Duodecim. 2002;118(20):2127-30. Finnish. No abstract available.

PMID:
12463004
36.

[Stem cell transplantations as a treatment of severe autoimmune diseases].

Jantunen E, Myllykangas-Luosujärvi R, Kaipiainen-Seppänen O, Mahlamäki E, Nousiainen T.

Duodecim. 2000;116(7):721-7. Review. Finnish. No abstract available.

PMID:
12078138
37.

[Chronic arthritis in Finland].

Kaipiainen-Seppänen O.

Duodecim. 2000;116(14):1445-51. Review. Finnish. No abstract available.

PMID:
12001459
38.

Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.

Möttönen T, Hannonen P, Korpela M, Nissilä M, Kautiainen H, Ilonen J, Laasonen L, Kaipiainen-Seppänen O, Franzen P, Helve T, Koski J, Gripenberg-Gahmberg M, Myllykangas-Luosujärvi R, Leirisalo-Repo M; FIN-RACo Trial Group. FINnish Rheumatoid Arthritis Combination therapy.

Arthritis Rheum. 2002 Apr;46(4):894-8.

39.

[Local treatment of pyoderma gangrenosum with cromoglycate solution].

Harvima RJ, Hollmén A, Mattila R, Kaipiainen-Seppänen O, Harvima IT, Kaminska R, Laukkanen A, Räsänen L, Horsmanheimo M.

Duodecim. 1999;115(19):2085-90. Finnish. No abstract available.

PMID:
11941802
40.

[Aseptic necrosis of both femurs in a man with panniculitis].

Myllykangas-Luosujärvi R, Kaipiainen-Seppänen O.

Duodecim. 1999;115(6):650-2. Finnish. No abstract available.

PMID:
11859498
41.

Carriers of the aspartylglucosaminuria genetic mutation and chronic arthritis.

Arvio M, Laiho K, Kauppi M, Peippo M, Leino P, Kautiainen H, Kaipiainen-Seppänen O, Mononen I.

Ann Rheum Dis. 2002 Feb;61(2):180-1.

42.

Changes in the incidence of juvenile rheumatoid arthritis in Finland.

Kaipiainen-Seppänen O, Savolainen A.

Rheumatology (Oxford). 2001 Aug;40(8):928-32.

PMID:
11511763
43.

Juvenile idiopathic arthritis in multicase families.

Säilä HM, Savolainen HA, Kotaniemi KM, Kaipiainen-Seppänen OA, Leirisalo-Repo MT, Aho KV.

Clin Exp Rheumatol. 2001 Mar-Apr;19(2):218-20.

PMID:
11326489
44.

Evaluation of iron status in anemic patients with rheumatoid arthritis using an automated immunoturbidimetric assay for transferrin receptor.

Punnonen K, Kaipiainen-Seppänen O, Riittinen L, Tuomisto T, Hongisto T, Penttilä L.

Clin Chem Lab Med. 2000 Dec;38(12):1297-300.

PMID:
11205697
45.

Adverse reactions to rifabutin.

Kaipiainen-Seppänen O, Hyvärinen L.

J Rheumatol. 2001 Jan;28(1):221-2. No abstract available.

PMID:
11196537
46.

Regional differences in the incidence of rheumatoid arthritis in Finland in 1995.

Kaipiainen-Seppänen O, Aho K, Nikkarinen M.

Ann Rheum Dis. 2001 Feb;60(2):128-32.

47.

Autologous peripheral blood stem cell transplantation in a patient with severe mixed connective tissue disease.

Myllykangas-Luosujärvi R, Jantunen E, Kaipiainen-Seppänen O, Mahlamäki E, Nousiainen T.

Scand J Rheumatol. 2000;29(5):326-7.

PMID:
11093601
48.

Intensive treatment of rheumatoid arthritis reduces need for dialysis due to secondary amyloidosis.

Kaipiainen-Seppänen O, Myllykangas-Luosujärvi R, Lampainen E, Ikäheimo R.

Scand J Rheumatol. 2000;29(4):232-5.

PMID:
11028844
49.

Autologous stem cell transplantation in a lymphoma patient with a long history of ankylosing spondylitis.

Jantunen E, Myllykangas-Luosujärvi R, Kaipiainen-Seppänen O, Nousiainen T.

Rheumatology (Oxford). 2000 May;39(5):563-4. No abstract available.

PMID:
10852991
50.

Incidence of chronic inflammatory joint diseases in Finland in 1995.

Kaipiainen-Seppänen O, Aho K.

J Rheumatol. 2000 Jan;27(1):94-100. Review.

PMID:
10648024

Supplemental Content

Loading ...
Support Center